Doehner, Hartmut, Luebbert, Michael, Fiedler, Walter, Fouillard, Loic, Haaland, Alf, Brandwein, Joseph M., Lepretre, Stephane, Reman, Oumedaly, Turlure, Pascal, Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330, Mueller-Tidow, Carsten, Kraemer, Alwin, Raffoux, Emmanuel, Doehner, Konstanze, Schlenk, Richard F., Voss, Florian, Taube, Tillmann, Fritsch, Holger and Maertens, Johan
2014.
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
Blood
124
(9)
, pp. 1426-1433.
10.1182/blood-2014-03-560557
|